Skip to main content
Facebook icon
Instagram Icon
Threads Icon
LinkedIn Icon
X icon

User account menu

  • Log in
Home
X

Main navigation

  • About
    • Overview
    • Leadership and Structure
    • Partners and Product Developers
  • Activity Hubs
    • Technology Accelerator
    • Design to Delivery
    • Business Market Dynamics and Commercialization
    • Capacity Strengthening Engagement and Mentorship
    • Clinical Trials
  • Products
    • Cabotegravir Injectable Depot
    • Cabotegravir Injectable Depot with Levonorgestrel
    • Cabotegravir Pellet Implant
    • Cabotegravir Pellet Implant with Levonorgestrel
    • Extended Release Dapivirine Vaginal Film
    • Extended Release Dapivirine Vaginal Film with Levonorgestrel
    • Griffithsin Fast Dissolving Vaginal Insert
    • Non-ARV/Non-Hormonal Multi-Purpose Vaginal Ring
    • TAF/EVG Fast Dissolving Vaginal Insert
  • News and More
    • Feature Stories and Profiles
    • MATRIX in the News
    • News Releases, Fact Sheets and QAs
    • HIV in the News
  • Research Highlights
    • Abstracts, Briefs and Publications
    • Meeting Materials, Presentations and Reports
    • Meetings and Webinars of Interest
  • People
    • Email Groups
  • Resources
    • MATRIX Policies
    • Regulatory Documents
  1. Home
  2. People Search
  3. wnyagah

Wawira Nyagah

Contact

Email: wawira@avac.org

Email Groups

List of email groups belonging to this person
Email Group Address Description
matrixd2dhub@matrix4prevention.org D2D Hub
matrixcollaborators@matrix4prevention.org MATRIX Collaborators (excludes SAG and USAID)
matrixtrihub@matrix4prevention.org MATRIX Tri-hub

This program was made possible by the generous support of the American people through the U.S. Agency for International Development (USAID) and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). The contents of this website are the responsibility of the MATRIX Consortium partners and do not necessarily reflect the views of USAID, PEPFAR, or the United States Government.

Main navigation

  • About
    • Overview
    • Leadership and Structure
    • Partners and Product Developers
  • Activity Hubs
    • Technology Accelerator
    • Design to Delivery
    • Business Market Dynamics and Commercialization
    • Capacity Strengthening Engagement and Mentorship
    • Clinical Trials
  • Products
    • Cabotegravir Injectable Depot
    • Cabotegravir Injectable Depot with Levonorgestrel
    • Cabotegravir Pellet Implant
    • Cabotegravir Pellet Implant with Levonorgestrel
    • Extended Release Dapivirine Vaginal Film
    • Extended Release Dapivirine Vaginal Film with Levonorgestrel
    • Griffithsin Fast Dissolving Vaginal Insert
    • Non-ARV/Non-Hormonal Multi-Purpose Vaginal Ring
    • TAF/EVG Fast Dissolving Vaginal Insert
  • News and More
    • Feature Stories and Profiles
    • MATRIX in the News
    • News Releases, Fact Sheets and QAs
    • HIV in the News
  • Research Highlights
    • Abstracts, Briefs and Publications
    • Meeting Materials, Presentations and Reports
    • Meetings and Webinars of Interest
  • People
    • Email Groups
  • Resources
    • MATRIX Policies
    • Regulatory Documents
Facebook icon
Instagram Icon
Threads Icon
LinkedIn Icon
X icon

Contact Us           Disclaimer           Privacy Policy

© The MATRIX Collaborative. All Rights Reserved.